DNA guanine N7 (N7-G)

DNA guanine N7 refers to the nitrogen atom at the 7th position of the guanine purine ring, which is the most nucleophilic site in the human genome (Source: PubChem, NIH). This site is the primary molecular target for a broad class of anticancer therapies, including platinum-based agents and alkylating agents (Source: StatPearls). When drugs like cisplatin or cyclophosphamide react with the N7 position, they form covalent DNA adducts that can lead to intrastrand or interstrand cross-links (Source: Wikipedia). These structural modifications physically impede the progression of DNA and RNA polymerases, thereby halting DNA replication and gene transcription (Source: PubMed). In malignant cells, which often have high proliferative rates and compromised repair mechanisms, this damage triggers cell cycle arrest and programmed cell death (apoptosis). Despite the emergence of targeted therapies, drugs hitting the DNA guanine N7 position remain foundational in treating various solid tumors and hematologic malignancies.

Other names

N7-guanineGuanine N7 positionN7-alkylguanine siteN7-methylguanine site

The mechanism involves the formation of a covalent bond between an electrophilic drug (or its active metabolite) and the nucleophilic N7 nitrogen of guanine. This results in mono-adducts or, more lethally, bifunctional cross-links that bridge two guanine bases on the same or opposite DNA strands (Source: StatPearls). These cross-links create physical roadblocks for replication and transcription machinery, leading to double-strand breaks and apoptosis (Source: NIH).